Related Experiment Video

Updated: Jun 28, 2025

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
11:31

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

10.0K

Leucine-Rich Repeat Kinases

Dario R Alessi1,2, Suzanne R Pfeffer1,3

  • 1Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, Maryland, USA.

Annual Review of Biochemistry
|April 15, 2024
PubMed

Insights

Activating mutations in leucine-rich repeat kinase 2 (LRRK2) cause Parkinson's disease by altering Rab GTPase function. Understanding LRRK2 structure and cell biology may lead to new LRRK2 inhibitors for patient benefit.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Neuroscience

Background:

  • Activating mutations in leucine-rich repeat kinase 2 (LRRK2) are the primary genetic cause of monogenic Parkinson's disease.
  • LRRK2 is a protein kinase phosphorylating Rab GTPases, crucial regulators of cellular transport pathways.
  • Dysregulated LRRK2 signaling contributes to Parkinson's pathogenesis.

Purpose of the Study:

  • To elucidate the structure, biochemical properties, and cell biology of LRRK2 and its paralog LRRK1.
  • To understand the mechanism of LRRK2-mediated Rab phosphorylation and its pathological consequences.
  • To explore the therapeutic potential of LRRK2 inhibitors for Parkinson's disease.

Main Methods:

  • Biochemical assays to study LRRK2 kinase activity and substrate interactions.
  • Cellular models to investigate LRRK2 localization, Rab phosphorylation, and downstream effects.
  • Structural biology techniques to determine LRRK2 and LRRK1 structures.

Main Results:

  • LRRK2 phosphorylates specific Rab GTPases, impairing their normal function and leading to membrane-bound, non-functional Rabs.
  • Phosphorylated Rabs gain new binding partners, such as RILPL1, contributing to disease pathology.
  • Rab proteins regulate LRRK2 activity and membrane recruitment, forming a feedback loop.
  • PPM1H acts as a counteracting phosphatase, dephosphorylating phospho-Rabs.

Conclusions:

  • LRRK2's role in Parkinson's disease is mediated through the aberrant phosphorylation of Rab GTPases.
  • Detailed understanding of LRRK2's molecular mechanisms provides a basis for developing targeted therapies.
  • Inhibiting LRRK2 activity holds promise for treating Parkinson's disease patients with LRRK2 mutations.
Keywords:
Crohn's diseasePPM1H phosphataseParkinson's diseaseRab GTPaseslysosomal stressneurodegeneration

More Related Videos

Assaying the Kinase Activity of LRRK2 in vitro06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

22.6K
Monitoring Leucine-Rich Repeat Containing 8 Channel (LRRC8/VRAC) Activity Using Sensitized-Emission Förster Resonance Energy Transfer (SE-FRET)08:54

Monitoring Leucine-Rich Repeat Containing 8 Channel (LRRC8/VRAC) Activity Using Sensitized-Emission Förster Resonance Energy Transfer (SE-FRET)

Published on: August 9, 2024

430

Related Concept Videos

Cell Signaling in Plants01:25

Cell Signaling in Plants

Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
5.6K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.8K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K